These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6995419)

  • 1. Prevention of emergence of bacterial resistance by combination of two antibiotics: rifampicin and trimethoprim.
    Grüneberg RN; Emmerson AM
    J Antimicrob Chemother; 1980 May; 6(3):349-56. PubMed ID: 6995419
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonistic interaction of rifampicin and trimethoprim.
    Harvey RJ
    J Antimicrob Chemother; 1978 Jul; 4(4):315-27. PubMed ID: 99420
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

  • 4. Trimethoprim and rifampicin: in vitro activities separately and in combination.
    Kerry DW; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1975 Dec; 1(4):417-27. PubMed ID: 1206027
    [No Abstract]   [Full Text] [Related]  

  • 5. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
    Küchler R; Koch UJ
    Chemotherapy; 1973; 18(4):242-52. PubMed ID: 4571975
    [No Abstract]   [Full Text] [Related]  

  • 6. [Microbiological studies on the combination effect of rifampicin and nalidixic acid (author's transl)].
    Ishiyama M; Nakazawa S
    Jpn J Antibiot; 1974 Oct; 27(5):643-52. PubMed ID: 4218271
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined action of sulphamethoxazole and trimethoprim against clinically-isolated sulphonamide-resistant bacteria.
    Grey D; Hamilton-Miller JM; Brumfitt W
    Chemotherapy; 1979; 25(5):296-302. PubMed ID: 383418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro.
    Soren O; Brinch KS; Patel D; Liu Y; Liu A; Coates A; Hu Y
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6233-40. PubMed ID: 26248380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the antibacterial activity of sulphonamide-trimethoprim combinations.
    Fourie ED; van Straten AM; Maritz HC; van Rensburg AJ
    S Afr Med J; 1979 Mar; 55(14):544-7. PubMed ID: 377523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of urinary pathogens to trimethoprim, nitrofurantoin and trimethoprim--nitrofurantoin combination.
    Anklesaria P; Paranjpe S; Gupta K; Acharya V; Paul T; Sheth UK
    J Postgrad Med; 1976 Oct; 22(4):171-5. PubMed ID: 802242
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance to trimethoprim in Klebsiellae isolated before its introduction.
    Hamilton-Miller JM; Grey D
    J Antimicrob Chemother; 1975 Jun; 1(2):213-8. PubMed ID: 1100591
    [No Abstract]   [Full Text] [Related]  

  • 13. Trimethoprim resistance determined by R factors.
    Fleming MP; Datta N; Grüneberg RN
    Br Med J; 1972 Mar; 1(5802):726-8. PubMed ID: 4552466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral antibiotics for infections due to multidrug-resistant Gram-negative organisms.
    Glasser JS; Markelz AE; Zera WC; Beckius ML; Mende K; Murray CK
    Scand J Infect Dis; 2011 Aug; 43(8):649-51. PubMed ID: 21466257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance.
    Wambaugh MA; Shakya VPS; Lewis AJ; Mulvey MA; Brown JCS
    PLoS Biol; 2017 Jun; 15(6):e2001644. PubMed ID: 28632788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim-sensitivity testing and thymineless mutants.
    Amyes SG; Smith JT
    J Med Microbiol; 1974 May; 7(2):143-53. PubMed ID: 4209268
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sensitivity of Brucella melitensis to various antibiotics, drug preparations and their combinations].
    Samarina IV; Taran IF; Proskurina VA; Liapustina LV
    Antibiot Khimioter; 1991 Apr; 36(4):22-3. PubMed ID: 1892428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The action of trimethoprim and rifampicin in combination against Gram-negative rods resistant to gentamicin.
    Farrell W; Wilks M; Drasar FA
    J Antimicrob Chemother; 1977 Sep; 3(5):459-62. PubMed ID: 903326
    [No Abstract]   [Full Text] [Related]  

  • 19. [Elimination of multiple resistance of enteric bacteria by acriflavine and experiments with trimethoprim for the same purpose].
    Türet S
    Mikrobiyol Bul; 1975; 9(2):93-100. PubMed ID: 778555
    [No Abstract]   [Full Text] [Related]  

  • 20. Trimethoprim, sulphamethoxazole, bacterial adhesion and polymorphonuclear leucocyte function.
    Emmanouilides CE; Lianou PE; Bassaris HP; Papavassiliou JT
    J Antimicrob Chemother; 1990 Dec; 26(6):803-12. PubMed ID: 2081720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.